Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR2A12 Inhibitors

OR2A12 inhibitors are a class of chemical compounds that interact with the olfactory receptor protein, specifically known as OR2A12. These receptors are part of a larger family of G-protein coupled receptors (GPCRs) that are responsible for the detection of odor molecules. OR2A12 is one of the many receptors in the olfactory system that contribute to the sense of smell by responding to specific chemical stimuli. Inhibitors targeting OR2A12 are designed to bind to this receptor and prevent its normal function, which is to activate a signal transduction pathway upon detection of its specific odorant molecule. By blocking the receptor's activity, these inhibitors effectively modulate the receptor's response to its ligand. The design and study of OR2A12 inhibitors involve understanding the structure and function of the OR2A12 receptor, as well as the molecular interactions that occur between the receptor and its ligands. This includes the analysis of the binding site and the way in which inhibitors fit into this space. The specificity of an OR2A12 inhibitor is crucial, as it must selectively interact with the OR2A12 receptor without significantly affecting the vast array of other olfactory receptors, each of which detects different odor molecules. The development of these inhibitors relies on advanced techniques in molecular biology, chemistry, and computational modeling to create molecules that can precisely interact with the OR2A12 receptor. Research in this field is driven by a fascination with the complexity of the olfactory system and an interest in the fundamental biochemical interactions between receptors and ligands.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SQ 22536

17318-31-9sc-201572
sc-201572A
5 mg
25 mg
$95.00
$363.00
13
(1)

SQ 22,536 acts as an adenylyl cyclase inhibitor, thereby reducing cAMP levels. Since OR2A12 is a G protein-coupled receptor that signals via cAMP, this compound indirectly leads to the decreased activity of OR2A12 by limiting its downstream signaling.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

KN-93 inhibits CaMKII, which is indirectly involved in OR2A12 signaling through modulation of intracellular calcium levels. Decreased activity of CaMKII can lead to an altered cellular response to OR2A12 activation.

Chelerythrine

34316-15-9sc-507380
100 mg
$540.00
(0)

Chelerythrine inhibits PKC, which can be activated downstream of G protein-coupled receptors like OR2A12. Inhibition of PKC results in decreased OR2A12-mediated responses.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$451.00
3
(1)

Pertussis toxin ADP-ribosylates and inactivates Gi/o proteins, which are one of the G protein subtypes that OR2A12 can couple to. This results in decreased OR2A12 signaling.

Paroxetine

61869-08-7sc-507527
1 g
$180.00
(0)

Paroxetine inhibits G protein-coupled receptor kinases (GRKs), which are responsible for phosphorylating activated receptors like OR2A12, leading to receptor desensitization. Inhibition of GRKs results in altered OR2A12 signaling dynamics.

ESI-09

263707-16-0sc-507491
5 mg
$230.00
(0)

ESI-09 inhibits Epac, which is a cAMP-regulated guanine nucleotide exchange factor involved in the signaling pathways of receptors such as OR2A12. By inhibiting Epac, the downstream effects of OR2A12 activation are reduced.